ECCO'25 Abstracts

ECCO'25 Abstracts on the JCC Website

ECCO'25 Abstract Book PDF Version

ECCO'25 Abstracts COI Disclosure

ECCO'24 Abstracts

ECCO'24 Abstracts on the JCC Website

ECCO'24 Abstract Book PDF Version

ECCO'24 Abstracts COI Disclosure

Poster presentations: Clinical: Diagnosis and Outcome 2021

P090 Risk of Rectal Cancer after Colectomy in Patients with Inflammatory Bowel Disease – A Nationwide Population-based Danish Cohort Study 1978-2018

P091 Switching to TNFi versus non-TNFi biologics in Crohn’s Disease patients: Real-world outcomes from a German claims data analysis

P092 Development and evaluation of i-Tracker Ustekinumab and i-Tracker Anti-ustekinumab kits: fast and innovative chemiluminescent assays for the monitoring of patients treated with ustekinumab

P093 COVID-19 lockdown and mental health burden in Inflammatory Bowel Disease paediatric patients: a case-control study

P094 Textbook outcome in Inflammatory Bowel Disease surgery

P095 Initial disease course in a Belgian, prospective inception cohort of patients with inflammatory bowel disease: the PANTHER cohort

P096 Which patients with known Crohn’s disease after an ileo-colonoscopy will benefit most from small bowel capsule endoscopy?

P097 Abnormal frailty screening is independently associated with both all-cause and disease-related hospital admissions in older patients with inflammatory bowel diseases.

P098 has been withdrawn

P099 Evaluation of endoscopic mayo score with an artificial intelligence algorithm

P100 Higher yield of serrated and adenomatous dysplasia detected with chromoendoscopy when compared with high-definition in patients with Primary Sclerosing Cholangitis and Inflammatory colitis.

P101 Fecal calprotectin is increased among patients with pouchitis and increases with increasing endoscopic subscores: Real-world data from a prospectively collected database

P102 Outcomes of coronavirus disease 2019 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort study

P103 Minimal Clinically Important Difference (MCID) for the Ulcerative Colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) Tool

P104 Inflammatory complications of the pouch, and therapetic requirements after colectomy in patients with ulcerative colitis. Results from the RESERVO Study of GETECCU

P105 Coping in Inflammatory Bowel Disease: insights from the Crohn’s and Colitis UK national survey

P106 Cromoendoscopy versus second generation Narrow band Imaging for dysplasia detection in IBD. An interim analysis of a prospective randomized control trial.

P107 Monitoring inflammatory bowel disease in clinical practice using gut microbial markers in faecal samples. Prospective study in a clinical cohort.

P108 has been withdrawn

P109 Impact of ethnicity on colorectal cancer incidence in a cohort of colitis-associated dysplasia patients

P110 Symptomology and most bothersome symptoms among pediatric Crohn’s disease and ulcerative colitis patients: Results from a physician and patient survey

P111 Cross-sectional imaging is highly sensitive in detecting endoscopic post-operative recurrence in Crohn’s disease patients

P112 Impact of the SARS-COV2 pandemic on patients with inflammatory bowel disease - Preliminary results of a prospective, single-center study

P113 Automatic detection of colonic ulcers and erosions in colon capsule endoscopy images using a convolutional neural network

P114 Frequent work productivity and activity impairment in caregivers of children with inflammatory bowel disease: a project of the prospective PIBD-SETQuality inception cohort study

P115 Chronic pouchitis and Crohn's disease of the pouch after ileal pouch-anal anastomosis : incidence and risk factors

P116 Development of a new patient-reported outcome measure for patients with complex cryptoglandular fistulas

P117 Patient perceptions about causes of flare in IBD: results from the baseline dataset of the PREdiCCt study

P118 External validation of model predicting early-onset surgery in Crohn’s Disease patients

P119 There is minimal agreement on the recognition of deep ulcers as seen on endoscopy in patients with Inflammatory Bowel Disease: a national survey

P120 Developing “My quality of life” programme based on ICHOM Standard Set for IBD: 1-year results

P121 The study of the hypercoagulable state in Crohn disease: Results of a prospective comparative study.

P122 Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department

P123 Type I collagen degradation fragments and type IV collagen formation/degradation ratio are serological biomarkers for stricturing (Montreal B2) Crohn's disease

P124 Gastroenteropancreatic Neuroendocrine Neoplasms in patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series

P125 Could gut microbiota metagenomic analysis improve diagnosis in paediatric Inflammatory Bowel Disease population?

P126 Older adults with acute severe ulcerative colitis have similar steroid failure and colectomy rates as younger adults

P127 Assessing the vaccination and immunization status in a Paediatric Inflammatory Bowel Disease diagnosis

P128 Depression, anxiety and stress among Inflammatory Bowel Disease patients during COVID-19: A UK cohort study

P129 IBD care in the UK: A comprehensive, novel service assessment with feedback from 10,222 patients and 166 NHS organisations to inform a vision for quality improvement

P130 Adhesions are not always the enemy: pouch volvulus

P131 Serum Proteomics and Intestinal Ultrasound Differentiates Fibrostenotic and Inflammatory Crohn’s Disease

P132 Uncovering blood biomarkers of Inflammatory Bowel Diseases by Raman spectroscopy and FAP dosage: toward a noninvasive triage of patients in first care diagnostic

P133 Clinical and ultrasonographic enthesitis in inflammatory bowel disease patients with and without psoriasis

P134 Ultrasonographic scores for Crohn’s disease activity assessment – still lag behind CEUS

P135 Proximal Extension of lower rectal Ulcerative Proctitis

P136 Management of patients with Inflammatory Bowel Disease and their outcome during the first wave of Covid-19 pandemics.

P137 Preliminary validation of a multi-stage machine learning algorithm to assess histological inflammation in inflammatory bowel disease

P138 Platelet-to-lymphocyte ratio index: a reliable tool for non-invasive assessment of endoscopic activity in small bowel Crohn’s Disease

P139 Significant Changes In Routine Biochemical Markers Occur Up To 5 Years Prior To Inflammatory Bowel Disease Diagnosis: A Case-Control Study

P140 Predicting Non-Responsiveness to Iron Therapy in Anaemic Children with Inflammatory Bowel Disease

P141 IBUS-SAS for Crohn’s disease ultrasound activity: initial validation and research of the optimal cut-off score

P142 Role of e-health in the management of Inflammatory Bowel Disease: A systematic review and meta-analysis

P143 Depression and anxiety symptoms among patients with early inflammatory bowel disease during and after COVID-19 lockdown

P144 Clock gene expression levels inversely correlate with disease activity in ulcerative colitis and Crohn’s disease

P145 Inflammatory Bowel Disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVIBD-Surg)

P146 The Toronto IBD global endoscopic reporting (TIGER) score demonstrates significant correlation with fecal calprotectin, CRP and IBD Disk in Crohn's disease patients

P147 Progression to biologic treatment in very early onset inflammatory bowel disease patients- a long term follow up retrospective study

P148 ANA and Anti-dsDNA antibody enabling the prediction of inflammatory arthritis in inflammatory bowel disease.

P149 Application of revised Pediatric Inflammatory Bowel Disease (PIBD) classes criteria to the Korean PIBD patients

P150 Histologic features predicting prognosis and their relationship with endoscopic findings in Ulcerative Colitis patients with mucosal healing

P151 Validation of the MaRIA Score in pediatric patients.

P152 Bowel ultrasound as an early monitoring tool to assess disease activity in Crohn’s disease patients after induction therapy with infliximab

P153 IBD patients’ treatment preferences are heterogeneous, but largely affected by the avoidance of abdominal pain and side effects (P-POWER IBD study)

P154 Faecal calprotectin and patient reported disease control of IBD: results from the baseline dataset of the PREdiCCt study

P155 Bowel preparation is valued more than colorectal cancer risk and interval by patients in colitis-associated colorectal cancer surveillance: a discrete choice experiment

P156 Translation into Spanish, adaptation and validation of the "IBD- control", a short validated English PRO (patients reported outcomes) questionnaire: the EII-Control

P157 Microbiome Analysis Reveals That Ralstonia is Responsible for Decreased Renal Function in Patients with Ulcerative Colitis

P158 Diagnostic yield of different imaging modalities (VCE, MRE and SBUS) in paediatric Inflammatory Bowel Disease patients

P159 Patients with Inflammatory Bowel Disease Present with Lower Trabecular Bone Scores

P160 Can the Lemann index at diagnosis predict the risk of early surgery in Crohn's disease?

P161 The impact of biologic therapies on Extra-Intestinal Manifestations in Inflammatory Bowel Disease: a multicentre observational study.

P162 Microscopic inflammation in limited Ulcerative Colitis at diagnosis: can a single histological feature predict prognosis?

P163 The impact of the COVID-19 pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease in The Netherlands.

P164 Celiac Disease among a large cohort of inflammatory bowel disease patients: epidemiology and outcome implications

P165 Non-invasive biomarkers of type III collagen cross-linking reflects fibrolysis in patient with luminal CROHN’S DISEASE

P166 Impact of consultation frequency and time to diagnosis on subsequent Inflammatory Bowel Disease outcomes

P167 Sexual dysfunction and associated factors in young patients with Crohn's disease

P168 Depression and fatigue dependent variation of gut microbiome in patients with active Inflammatory Bowel Disease

P169 Vitamin D levels are inversely associated with inflammation in pediatric InflammatoryBowel Disease patients

P170 Correlation between health-related quality of life and smartphone-based self-assessment of activity index in patients with ulcerative colitis

P171 Immune-mediated diseases (IMID) and COVID-19: results from an observational retrospective multicenter study

P172 Clinical characteristics of newly diagnosed adult patients with Crohn's disease in Japan: Interim analysis of Inception cohort registry study of patients with Crohn's disease (iCREST-CD)

P173 Subfertility in young women and men patients with Crohn´s disease

P174 Defining Crohn's Disease Strictures Using Intestinal Ultrasound Compared to Histopathology

P175 Complete endoscopic healing is associated with lower disability than partial mucosal healing in Crohn’s disease: a prospective multicentric study.

P176 Patient preferences in steroid resistant ulcerative colitis – a discrete choice experiment survey

P177 Adherence to a bowel cleansing regimen for pan-enteric capsule endoscopy in patients with suspected Crohn’s disease and factors affecting the image quality

P178 Remote monitoring as an effective management strategy in inflammatory bowel disease: the lesson from COVID-19 pandemic

P179 Treatment decisions and biologic adoption rates in newly diagnosed Crohn's disease in Japan

P180 Endoscopic scoring systems for Crohn’s Disease and Ulcerative Colitis and their correlation with histological and clinical outcomes

P181 Patient-led remote intracapillary pharmacokinetic sampling (fingerPRICKS) for therapeutic drug monitoring in patients with Inflammatory Bowel Disease

P182 Bowel wall thickness as seen on point-of-care intestinal ultrasound correlates with endoscopic severity in children with Inflammatory Bowel Disease: A North American diagnostic cross-sectional study

P183 Risk of eating disorders in italian children and adolescents with Inflammatory Bowel Disease: results of a multicenter nationwide study

P184 Disease activity in Inflammatory Bowel Disease patients is associated with increased liver fat content during follow-up

P185 Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain

P186 Inflammatory Bowel Disease Care in the Covid-19 pandemic era: Experience from a Tunisian gastroenterology department

P187 Change in Urgency Status Among Ulcerative Colitis Patients: Understanding the Impact of Treatment Changes from the Corrona Inflammatory Bowel Disease Registry

P188 Artificial Intelligence and Colon Capsule Endoscopy: Automatic detection of colonic mucosal lesions and blood using a convolutional neural network

P189 has been withdrawn

P190 Ileo-caecal Crohn’s Disease; medical or surgical management. Cost and outcomes.

P191 Non-specific terminal ileitis: prevalence, clinical course and association with later diagnosis of Crohn’s disease

P192 Frequency of hereditary and acquired thromboembolic complications in patients with inflammatory bowel diseases in Moscow Clinical Scientific Center named after A.S. Loginov

P193 Assessement of cumulative bowel damage using Lemann index and MaRIA score in surgically naive patients with Crohn's disease

P194 Alexithymia traits are associated with symptom severity and disease activity in IBD patients

P195 Predictors of colectomy in patients with acute severe ulcerative colitis: single-center retrospective analysis.

P196 Colon-involving versus non-colon-involving Crohn’s disease classification: is the Montreal classification outdated?

P197 The effect of a positive family history on the phenotype and course of paediatric Inflammatory Bowel Disease

P198 Practical deep learning tool for the scoring of ulcerative colitis disease activity in central reading

P199 Analysis of clinical features of asymptomatic perianal fistulizing Crohn's disease

P200 Celiac disease (CD) and CHRONIC INFLAMMATORY BOWEL DISEASE (IBD) association

P201 Evaluation of the role of anti-TNF in stabilizing the progression of intestinal lesions in Crohn's disease using the Lemann Index

P202 De novo Inflamatory Bowel Disease after solid organ transplantation

P203 Sexual Dysfunction in Chronic Inflammatory Bowel Disease: Myth or Reality?

P204 Elevated Fecal Calprotectin Levels Predict Flare-up in Patients with Inflammatory Bowel Disease During International Air Travel

P205 Influencing factors of Sleep quality in patients with Crohn's Disease

P206 Paediatric Genital Crohn’s Disease: Presentation and Treatment, a combined case series

P207 Clinical outcome of patients with Ulcerative colitis after anti-TNF discontinuation -\t10 years follow up

P208 Differentiating intestinal tuberculosis from Crohn's Disease: External validation of a new nomogram

P209 Prevalence and risk factors for fatigue in chronic inflammatory bowel disease

P210 Healthcare resources utilisation prior to the diagnosis of ulcerative colitis and Crohn’s disease

P211 Pseudopolyps are associated with increased fecal calprotectin levels in patients with Inflammatory Bowel Disease in clinical and endoscopic remission.

P212 Assessment of Crohn's disease activity using global MaRIA score in patients with ileal and ileocolonic disease

P213 Having Inflammatory Bowel Disease Negatively Impacts Household and Family Life

P214 Faecal S100A12 as a non-invasive marker of inflammatory activity in pediatric Inflammatory Bowel Disease

P215 Blood-based prognostic biomarkers in Crohn’s patients treated with biologics: a new promising tool to predict endoscopic outcomes

P216 Comparative Assessment C-reactive Protein Between a Point-of-Care Testing and Current Standard of Care (Immunonephelometric testing)

P217 Clostridium Difficile Infection as a cause of severe outcomes in patients with Inflammatory Bowel Disease

P218 Assessment of the degree of intestinal destruction in Crohn's disease at the time of diagnosis

P219 An application of artificial intelligence in Inflammatory Bowel Disease detection

P220 Patient-entered symptoms scores collected using a new IBD patient portal correlate closely with clinical assessment and can optimise delivery of IBD care

P221 Crohn’s disease patients unable to complete preoperative mechanical bowel preparation have increased risk of anastomotic complications: results of a prospective observational study

P222 Heart rate variability is a predictor to disease exacerbation in paediatric Inflammatory Bowel Disease

P223 Degree of Histological Activity is not Associated with Vedolizumab Therapy Outcome in Ulcerative Colitis

P224 Regular physical activity on IBD patients: impact on IBD natural history and related comorbidities

P225 Impact of Inflammatory Bowel Diseases on patients working life

P226 Does faecal Calprotectin help differentiate inflammatory from fibrous stenosis in Crohn’s disease?

P227 Timing of acute severe colitis in the course of an inflammatory bowel disease: is it a prognostic factor?

P228 Prehabilitation strategies prior to ileocolonic resection in Crohn’s disease in a prospective cohort study: a missed window of opportunity?

P229 Standardization of Quantum Blue® rapid TDM assays with WHO international standards for adalimumab and infliximab

P230 Development of a Japanese version of the IBD Self-Efficacy Scale and evaluation of its current status in Japan

P231 Work productivity loss in perianal crohn's disease

P232 Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease.

P233 Sleep Disorders and Chronic Inflammatory Bowel Disease: What's the Connection?

P234 Association between anti-TNFα drug levels and drug-induced lupus in patients with Inflammatory Bowel Disease

P235 Major Depression in patients with Crohn's disease and its relationship with clinical activity and disease’s phenotype.

P236 Low Social support and distinct anxiety as a crucial feature in depressive IBD patients

P237 Prevalence of dysplasia and colorectal cancer in Ulcerative Colitis patients from a referral center in Latin America

P238 Enteropathy associated T-cell lymphoma as a diagnostic challenge in young patient with Crohn’s disease

P239 A study to evaluate uptake of PROMS for IBD patients on Biologics : a sample United Kingdom district general hospital experience.

P240 Clinical diagnostics of fecal calprotectin: a comparative study of a semi-quantitative rapid test and a quantitative lab test

P241 Gastrointestinal ultrasound instead of magnetic resonance enterography: Large potential cost savings with limited clinical downsides

P242 Newly diagnosed Inflammatory Bowel Disease patients referred via the Straight To Test Lower GI two week wait pathway, Single Centre Study.

P243 Elevated presepsin levels are a marker of sepsis risk in patients with inflammatory bowel diseases receiving therapy of TNF-α blockers.

P244 Clinician preferences in treating steroid resistant ulcerative colitis: a discrete-choice experiment (DCE) survey

P245 Evaluation of quality of life in patients with perineal Crohn’s disease: a monocentric Tunisien study

P246 Development of a new Inflammatory Bowel Disease Patient Identifier shortens time to clinic review and initiation of treatment

P247 Carotid Plaque Assessment reclassifies patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk

P248 Assessment of health-related quality of life of paediatric Inflammatory Bowel Disease patients through the IMPACT-III questionnaire

P249 What’s the role of anti-TNF α in correcting anemia in Crohn’s disease?

P250 Does Ethnicity Influence Patient’s Preferences for Treatment Outcome? The Israeli Experience

P251 Antiphospholipid antibodies in Crohn's disease: Results of a prospective single-center study

P252 Medication adherence in inflammatory bowel diseases in the era of biotherapies

P253 A qualitative study exploring meaningful improvement in bowel urgency among adults with moderate to severe Ulcerative Colitis.

P254 Factors that may predict the need for infliximab optimization in Crohn's disease

P255 Efficacy and safety of a restrictive ferric carboxymaltose infusion strategy for iron deficiency anemia in inflammatory bowel disease patients.

P256 High disease burden of CROHN'S DISEASE (CD) in a Latin American IBD reference center

P257 Assessment of the nutritional status of pediatric Inflammatory Bowel Disease patients according to disease activity.

P258 Rates of admission of acute IBD flares during the COVID-19 pandemic in a tertiary healthcare setting